EUVIMEDOpdag EUVIMED
ÜbersichtsarbeitFallberichtOpen access · CC BY 4.0

Hypertrophic Cardiomyopathy as a Key Feature of MRAS‐Related Noonan Syndrome: New Case and Comprehensive Literature Review

Romain Martineau iD, Constance Wells, Florent Fuchs, Sophie Collardeau-Frachon iD, Valentin Ruault iD, Sophie Colomb iD, Jean-Michel Faure, Caroline Bartholmot, Marie Vincenti, Benjamin Ganne, Marjolaine Willems iD

Prenatal Diagnosis · 2026-04 · 46 (4) · 581-588

DOI: 10.1002/pd.70134 ↗

At a glance

Übersichtsarbeit in Prenatal Diagnosis, published online on 2026-03-22. Written by Romain Martineau and 10 co-authors. Institution: Resident in Gynecology, Obstetrics and Fetopathology, Montpellier University, Montpellier, France. Major MEDLINE topics: Noonan Syndrome, Cardiomyopathy, Hypertrophic. 23 references. The full text is freely available (open access, CC BY 4.0).

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Noonan syndrome (NS) is a rare multisystemic condition among the RASopathy group, characterized by a broad phenotypic spectrum and genetic variability. It results from pathogenic variants in genes regulating the RAS/MAPK pathway, affecting cell proliferation and differentiation. While the PTPN11 gene accounts for approximately 50% of cases, other genes, including MRAS , have been implicated. NS presents with features such as facial dysmorphism, short stature, and cardiac anomalies. Hypertrophic cardiomyopathy (HCM) is a major contributor to mortality, with specific variants conferring higher risk. This article includes a review of the literature on NS with pathogenic MRAS variants and describes an eighth case, the first documented with early and severe antenatal manifestations. The fetus exhibited increased nuchal translucency, agenesis of the ductus venosus, pulmonary lymphangiectasia, and complex hepatic vascular anomalies. A cesarean section was performed at 33 weeks' gestation due to worsening fetal pleural effusions and maternal intolerance to polyhydramnios. Despite intensive postnatal care, the newborn died from refractory shock and multi‐organ failure. Histopathology revealed HCM, obliterative portal venopathy and lymphangiectasia, consistent with NS pathology. These findings suggest that pathogenic MRAS variants confer a high risk of severe HCM (100% of cases). Moreover, emerging targeted therapies, such as MEK inhibitors, offer potential for treatment.

Subjects

MeSH terms (MEDLINE)

Noonan SyndromeCardiomyopathy, HypertrophicHumansFemalePregnancyAdultInfant, NewbornProtein Tyrosine Phosphatase, Non-Receptor Type 11Fatal Outcome

Author keywords

MRASRASopathiesfetal pathologyhypertrophic cardiomyopathynoonan syndromeprenatal

Substances

PTPN11 protein, humanProtein Tyrosine Phosphatase, Non-Receptor Type 11

Authors and institutions

  • Resident in Gynecology, Obstetrics and Fetopathology, Montpellier University, Montpellier, France.
  • Medical Genetics Department, University Hospital of Montpellier, Montpellier University, Montpellier, France.
  • Department of Obstetrics and Gynecology, University Hospital of Montpellier, Montpellier University, Montpellier, France.
  • Inserm, CESP Center for Research in Epidemiology and Population Health, Reproduction and Child Development, Villejuif, France.
  • DESBREST Institute of Epidemiology and Public Health (IDESP), University of Montpellier, INSERM, Montpellier, France.
  • Department of Pathology, Hospices Civils de Lyon & Université Claude Bernard Lyon 1, Lyon, France.

ORCID profiles: Romain Martineau, Sophie Collardeau-Frachon, Valentin Ruault, Sophie Colomb, Marjolaine Willems

Cite

APA

Martineau, R., Wells, C., Fuchs, F., Collardeau-Frachon, S., Ruault, V., Colomb, S., Faure, J. M., Bartholmot, C., Vincenti, M., Ganne, B., & Willems, M. (2026). Hypertrophic Cardiomyopathy as a Key Feature of MRAS‐Related Noonan Syndrome: New Case and Comprehensive Literature Review. Prenatal Diagnosis, 46(4), 581-588. https://doi.org/10.1002/pd.70134

Vancouver

Martineau R, Wells C, Fuchs F, Collardeau-Frachon S, Ruault V, Colomb S, et al. Hypertrophic Cardiomyopathy as a Key Feature of MRAS‐Related Noonan Syndrome: New Case and Comprehensive Literature Review. Prenatal Diagnosis. 2026;46(4):581-588. doi:10.1002/pd.70134

BibTeX
@article{Martineau2026,
  author = {Martineau, Romain and Wells, Constance and Fuchs, Florent and Collardeau-Frachon, Sophie and Ruault, Valentin and Colomb, Sophie and Faure, Jean-Michel and Bartholmot, Caroline and Vincenti, Marie and Ganne, Benjamin and Willems, Marjolaine},
  title = {Hypertrophic Cardiomyopathy as a Key Feature of MRAS‐Related Noonan Syndrome: New Case and Comprehensive Literature Review},
  journal = {Prenatal Diagnosis},
  year = {2026},
  volume = {46},
  number = {4},
  pages = {581--588},
  doi = {10.1002/pd.70134}
}
Start for free →